papers/abateDistinctViralMutational2015a.md
... ...
@@ -30,12 +30,11 @@ All other BL studies, BL Tier 1, 29
30 30
All other BL studies, BL Tier 2, 156
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|BL tier|
37 35
|:-|:-:|
38 36
|[CCNF](../CCNF)|2 |
39 37
38
+
40 39
# Details
41 40
papers/arthurGenomewideDiscoverySomatic2018.md
... ...
@@ -30,31 +30,36 @@ All other DLBCL studies, DLBCL Tier 1, 120
30 30
All other DLBCL studies, DLBCL Tier 2, 186
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[AICDA](../AICDA)|2 |
39 38
|[BCL7A](../BCL7A)|1 |
40
-|[BIRC3](../BIRC3)|2 |
41
-|[CD44](../CD44)|2 |
42
-|[CD74](../CD74)|2 |
43 39
|[ETV6](../ETV6)|1 |
44 40
|[GRHPR](../GRHPR)|1 |
45 41
|[LCOR](../LCOR)|1 |
46
-|[LPP](../LPP)|2 |
47
-|[MALAT1](../MALAT1)|2 |
48 42
|[MEF2C](../MEF2C)|1 |
49
-|[NEAT1](../NEAT1)|2 |
50 43
|[OSBPL10](../OSBPL10)|1 |
51 44
|[PIM2](../PIM2)|1 |
45
+|[ZC3H12A](../ZC3H12A)|1 |
46
+
47
+### Tier 2
48
+|New gene|DLBCL tier|
49
+|:-|:-:|
50
+|[AICDA](../AICDA)|2 |
51
+|[BIRC3](../BIRC3)|2 |
52
+|[CD44](../CD44)|2 |
53
+|[CD74](../CD74)|2 |
54
+|[LPP](../LPP)|2 |
55
+|[MALAT1](../MALAT1)|2 |
56
+|[NEAT1](../NEAT1)|2 |
52 57
|[RFTN1](../RFTN1)|2 |
53 58
|[SERPINA9](../SERPINA9)|2 |
54 59
|[ST6GAL1](../ST6GAL1)|2 |
55 60
|[TBC1D4](../TBC1D4)|2 |
56
-|[ZC3H12A](../ZC3H12A)|1 |
57 61
|[ZCCHC7](../ZCCHC7)|2 |
58 62
63
+
59 64
# Details
60 65
papers/barariaCathepsinAlterationsInduce2020c.md
... ...
@@ -30,12 +30,13 @@ All other FL studies, FL Tier 1, 65
30 30
All other FL studies, FL Tier 2, 50
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38 38
|[CTSS](../CTSS)|1 |
39 39
40
+
40 41
# Details
41 42
papers/bohleRoleEarlyBcell2013.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[EBF1](../EBF1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/braggioGenomicAnalysisMarginal2012.md
... ...
@@ -30,12 +30,13 @@ All other MZL studies, MZL Tier 1, 41
30 30
All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38 38
|[ATM](../ATM)|1 |
39 39
40
+
40 41
# Details
41 42
papers/burkhardtClinicalRelevanceMolecular2022b.md
... ...
@@ -30,9 +30,7 @@ All other BL studies, BL Tier 1, 29
30 30
All other BL studies, BL Tier 2, 132
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|BL tier|
37 35
|:-|:-:|
38 36
|[ADAMTS5](../ADAMTS5)|2 |
... ...
@@ -61,5 +59,6 @@ All other BL studies, BL Tier 2, 132
61 59
|[ZBTB7A](../ZBTB7A)|2 |
62 60
|[ZNF85](../ZNF85)|2 |
63 61
62
+
64 63
# Details
65 64
papers/chapuyMolecularSubtypesDiffuse2018b.md
... ...
@@ -30,9 +30,15 @@ All other DLBCL studies, DLBCL Tier 1, 126
30 30
All other DLBCL studies, DLBCL Tier 2, 181
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|DLBCL tier|
37
+|:-|:-:|
38
+|[HIST1H1B](../HIST1H1B)|1 |
39
+|[LTB](../LTB)|1 |
40
+
41
+### Tier 2
36 42
|New gene|DLBCL tier|
37 43
|:-|:-:|
38 44
|[CCL4](../CCL4)|2 |
... ...
@@ -41,9 +47,7 @@ All other DLBCL studies, DLBCL Tier 2, 181
41 47
|[DOCK1](../DOCK1)|2 |
42 48
|[FUT5](../FUT5)|2 |
43 49
|[GABRA2](../GABRA2)|2 |
44
-|[HIST1H1B](../HIST1H1B)|1 |
45 50
|[IL6](../IL6)|2 |
46
-|[LTB](../LTB)|1 |
47 51
|[LYN](../LYN)|2 |
48 52
|[NANOG](../NANOG)|2 |
49 53
|[NAV1](../NAV1)|2 |
... ...
@@ -55,5 +59,6 @@ All other DLBCL studies, DLBCL Tier 2, 181
55 59
|[TLR2](../TLR2)|2 |
56 60
|[ZNF423](../ZNF423)|2 |
57 61
62
+
58 63
# Details
59 64
papers/cheungAcquiredTNFRSF14Mutations2010a.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|1|0|
12 11
|FL|1|0|
12
+|DLBCL|1|0|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -31,12 +31,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
31 31
All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
37
-|New gene|DLBCL tier|FL tier|
36
+### Tier 1
37
+|New gene|FL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39 39
|[TNFRSF14](../TNFRSF14)|1 |1 |
40 40
41
+
41 42
# Details
42 43
papers/compagnoMutationsMultipleGenes2009a.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[TNFAIP3](../TNFAIP3)|1 |
39 39
40
+
40 41
# Details
41 42
papers/deschGenotypingCirculatingTumor2020.md
... ...
@@ -30,9 +30,14 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 73
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|PMBL tier|
37
+|:-|:-:|
38
+|[LTB](../LTB)|1 |
39
+
40
+### Tier 2
36 41
|New gene|PMBL tier|
37 42
|:-|:-:|
38 43
|[ACTG1](../ACTG1)|2 |
... ...
@@ -43,8 +48,8 @@ All other PMBL studies, PMBL Tier 2, 73
43 48
|[IGLL5](../IGLL5)|2 |
44 49
|[KLF2](../KLF2)|2 |
45 50
|[KMT2D](../KMT2D)|2 |
46
-|[LTB](../LTB)|1 |
47 51
|[MYB](../MYB)|2 |
48 52
53
+
49 54
# Details
50 55
papers/dunsCharacterizationDLBCLPMBL2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|8|3|
12 11
|PMBL|6|8|
12
+|DLBCL|8|3|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -31,25 +31,30 @@ All other PMBL studies, PMBL Tier 1, 70
31 31
All other PMBL studies, PMBL Tier 2, 74
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
37
-|New gene|DLBCL tier|PMBL tier|
36
+### Tier 1
37
+|New gene|PMBL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[BIRC3](../BIRC3)|2 |2 |
40 39
|[CD83](../CD83)|1 |1 |
41 40
|[CREBBP](../CREBBP)|1 |1 |
42 41
|[DUSP2](../DUSP2)|1 |1 |
43
-|[FOXO1](../FOXO1)|1 |2 |
44
-|[HRNR](../HRNR)| |2 |
42
+|[FOXO1](../FOXO1)|2 |1 |
45 43
|[IL4R](../IL4R)|1 |1 |
46
-|[LPHN3](../LPHN3)| |2 |
47
-|[MCL1](../MCL1)|2 |2 |
48
-|[MYC](../MYC)|1 |2 |
44
+|[MYC](../MYC)|2 |1 |
49 45
|[PIM1](../PIM1)|1 |1 |
50
-|[RFTN1](../RFTN1)|2 |2 |
51 46
|[SGK1](../SGK1)|1 |1 |
52
-|[WDR87](../WDR87)| |2 |
47
+
48
+### Tier 2
49
+|New gene|PMBL tier|DLBCL tier|
50
+|:-|:-:|:-:|
51
+|[BIRC3](../BIRC3)|2 |2 |
52
+|[HRNR](../HRNR)|2 | |
53
+|[LPHN3](../LPHN3)|2 | |
54
+|[MCL1](../MCL1)|2 |2 |
55
+|[RFTN1](../RFTN1)|2 |2 |
56
+|[WDR87](../WDR87)|2 | |
57
+
53 58
54 59
# Details
55 60
papers/ganapathiGeneticLandscapeDural2016.md
... ...
@@ -30,12 +30,13 @@ All other MZL studies, MZL Tier 1, 41
30 30
All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38 38
|[KLHL6](../KLHL6)|1 |
39 39
40
+
40 41
# Details
41 42
papers/gomezUltraDeepSequencingReveals2023.md
... ...
@@ -30,18 +30,23 @@ All other PMBL studies, PMBL Tier 1, 74
30 30
All other PMBL studies, PMBL Tier 2, 77
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[ARID5B](../ARID5B)|1 |
39
+|[DTX1](../DTX1)|1 |
40
+
41
+### Tier 2
42
+|New gene|PMBL tier|
43
+|:-|:-:|
39 44
|[AXDND1](../AXDND1)|2 |
40 45
|[CDH5](../CDH5)|2 |
41
-|[DTX1](../DTX1)|1 |
42 46
|[HLA-C](../HLA-C)|2 |
43 47
|[LIMD2](../LIMD2)|2 |
44 48
|[OR13C2](../OR13C2)|2 |
45 49
50
+
46 51
# Details
47 52
papers/grandeGenomewideDiscoverySomatic2019.md
... ...
@@ -30,24 +30,29 @@ All other BL studies, BL Tier 1, 20
30 30
All other BL studies, BL Tier 2, 153
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[BACH2](../BACH2)|2 |
39 38
|[BCL7A](../BCL7A)|1 |
40
-|[CDKN2A](../CDKN2A)|2 |
41 39
|[CHD8](../CHD8)|1 |
42 40
|[GNAI2](../GNAI2)|1 |
43
-|[HIST1H1E](../HIST1H1E)|2 |
44 41
|[KMT2D](../KMT2D)|1 |
45
-|[MIR142](../MIR142)|2 |
46 42
|[RFX7](../RFX7)|1 |
47 43
|[SIN3A](../SIN3A)|1 |
48 44
|[TCL1A](../TCL1A)|1 |
49 45
|[TFAP4](../TFAP4)|1 |
50 46
|[USP7](../USP7)|1 |
51 47
48
+### Tier 2
49
+|New gene|BL tier|
50
+|:-|:-:|
51
+|[BACH2](../BACH2)|2 |
52
+|[CDKN2A](../CDKN2A)|2 |
53
+|[HIST1H1E](../HIST1H1E)|2 |
54
+|[MIR142](../MIR142)|2 |
55
+
56
+
52 57
# Details
53 58
papers/gunawardanaRecurrentSomaticMutations2014c.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[PTPN1](../PTPN1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/hubschmannMutationalMechanismsShaping2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|3|23|
12 11
|FL|2|15|
12
+|DLBCL|3|23|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -31,49 +31,54 @@ All other DLBCL studies, DLBCL Tier 1, 125
31 31
All other DLBCL studies, DLBCL Tier 2, 175
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
37
-|New gene|DLBCL tier|FL tier|
36
+### Tier 1
37
+|New gene|FL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[ACTG1](../ACTG1)|1 |2 |
40
-|[ADAMTS1](../ADAMTS1)|2 | |
41
-|[ANKRD12](../ANKRD12)|2 | |
42
-|[ATP6V1A](../ATP6V1A)| |2 |
43
-|[CADPS2](../CADPS2)|2 | |
44
-|[CCDC42BPB](../CCDC42BPB)| |2 |
45
-|[CNOT2](../CNOT2)|2 | |
46
-|[CPNE8](../CPNE8)| |2 |
47
-|[DHX15](../DHX15)| |2 |
48
-|[DHX16](../DHX16)|2 | |
49
-|[DNM2](../DNM2)|2 | |
39
+|[ACTG1](../ACTG1)|2 |1 |
50 40
|[EEF1A1](../EEF1A1)|1 |1 |
51
-|[FBXO11](../FBXO11)|1 | |
52
-|[FZR1](../FZR1)| |2 |
53
-|[GAK](../GAK)|2 | |
54
-|[HLA-DQA1](../HLA-DQA1)|2 | |
55
-|[IKBKE](../IKBKE)|2 | |
56
-|[IRF1](../IRF1)|2 | |
57
-|[JUP](../JUP)| |2 |
41
+|[FBXO11](../FBXO11)| |1 |
42
+|[VMA21](../VMA21)|1 | |
43
+
44
+### Tier 2
45
+|New gene|FL tier|DLBCL tier|
46
+|:-|:-:|:-:|
47
+|[ADAMTS1](../ADAMTS1)| |2 |
48
+|[ANKRD12](../ANKRD12)| |2 |
49
+|[ATP6V1A](../ATP6V1A)|2 | |
50
+|[CADPS2](../CADPS2)| |2 |
51
+|[CCDC42BPB](../CCDC42BPB)|2 | |
52
+|[CNOT2](../CNOT2)| |2 |
53
+|[CPNE8](../CPNE8)|2 | |
54
+|[DHX15](../DHX15)|2 | |
55
+|[DHX16](../DHX16)| |2 |
56
+|[DNM2](../DNM2)| |2 |
57
+|[FZR1](../FZR1)|2 | |
58
+|[GAK](../GAK)| |2 |
59
+|[HLA-DQA1](../HLA-DQA1)| |2 |
60
+|[IKBKE](../IKBKE)| |2 |
61
+|[IRF1](../IRF1)| |2 |
62
+|[JUP](../JUP)|2 | |
58 63
|[LAPTM5](../LAPTM5)|2 |2 |
59
-|[LRP12](../LRP12)|2 | |
60
-|[MGEA5](../MGEA5)| |2 |
61
-|[MYCBP2](../MYCBP2)| |2 |
62
-|[N2RF2](../N2RF2)|2 | |
64
+|[LRP12](../LRP12)| |2 |
65
+|[MGEA5](../MGEA5)|2 | |
66
+|[MYCBP2](../MYCBP2)|2 | |
67
+|[N2RF2](../N2RF2)| |2 |
63 68
|[PDS5B](../PDS5B)|2 |2 |
64
-|[PNPO](../PNPO)|2 | |
65
-|[PPP4C](../PPP4C)| |2 |
69
+|[PNPO](../PNPO)| |2 |
70
+|[PPP4C](../PPP4C)|2 | |
66 71
|[PRKDC](../PRKDC)|2 |2 |
67
-|[RAC2](../RAC2)|2 | |
68
-|[RBM6](../RBM6)| |2 |
69
-|[SIAH2](../SIAH2)|2 | |
70
-|[SLC34A2](../SLC34A2)|2 | |
71
-|[TPP1](../TPP1)| |2 |
72
-|[TRAF6](../TRAF6)|2 | |
73
-|[UNC5B](../UNC5B)|2 | |
74
-|[VMA21](../VMA21)| |1 |
75
-|[WNK1](../WNK1)|2 | |
76
-|[ZNF217](../ZNF217)|2 | |
72
+|[RAC2](../RAC2)| |2 |
73
+|[RBM6](../RBM6)|2 | |
74
+|[SIAH2](../SIAH2)| |2 |
75
+|[SLC34A2](../SLC34A2)| |2 |
76
+|[TPP1](../TPP1)|2 | |
77
+|[TRAF6](../TRAF6)| |2 |
78
+|[UNC5B](../UNC5B)| |2 |
79
+|[WNK1](../WNK1)| |2 |
80
+|[ZNF217](../ZNF217)| |2 |
81
+
77 82
78 83
# Details
79 84
papers/jalladesExomeSequencingIdentifies2017.md
... ...
@@ -30,16 +30,21 @@ All other MZL studies, MZL Tier 1, 40
30 30
All other MZL studies, MZL Tier 2, 48
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|MZL tier|
37
+|:-|:-:|
38
+|[CCND3](../CCND3)|1 |
39
+|[KLF2](../KLF2)|1 |
40
+
41
+### Tier 2
36 42
|New gene|MZL tier|
37 43
|:-|:-:|
38 44
|[ARHGAP20](../ARHGAP20)|2 |
39 45
|[ARHGEF15](../ARHGEF15)|2 |
40 46
|[ARHGEF17](../ARHGEF17)|2 |
41 47
|[BCOR](../BCOR)|2 |
42
-|[CCND3](../CCND3)|1 |
43 48
|[DNAH5](../DNAH5)|2 |
44 49
|[DNAH7](../DNAH7)|2 |
45 50
|[DNAI1](../DNAI1)|2 |
... ...
@@ -53,7 +58,6 @@ All other MZL studies, MZL Tier 2, 48
53 58
|[KAT6A](../KAT6A)|2 |
54 59
|[KDM6A](../KDM6A)|2 |
55 60
|[KIF26A](../KIF26A)|2 |
56
-|[KLF2](../KLF2)|1 |
57 61
|[MGA](../MGA)|2 |
58 62
|[MYC](../MYC)|2 |
59 63
|[MYLK](../MYLK)|2 |
... ...
@@ -64,5 +68,6 @@ All other MZL studies, MZL Tier 2, 48
64 68
|[TBK1](../TBK1)|2 |
65 69
|[WNK1](../WNK1)|2 |
66 70
71
+
67 72
# Details
68 73
papers/jardinRecurrentMutationsExportin2016a.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[XPO1](../XPO1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/johnstonCmycHypermutationBurkitt1992.md
... ...
@@ -30,12 +30,13 @@ All other BL studies, BL Tier 1, 28
30 30
All other BL studies, BL Tier 2, 157
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38 38
|[MYC](../MYC)|1 |
39 39
40
+
40 41
# Details
41 42
papers/khodabakhshiRecurrentTargetsAberrant2012.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[CXCR4](../CXCR4)|1 |
39 39
40
+
40 41
# Details
41 42
papers/krysiakRecurrentSomaticMutations2017b.md
... ...
@@ -30,16 +30,14 @@ All other FL studies, FL Tier 1, 49
30 30
All other FL studies, FL Tier 2, 45
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38 38
|[ARID1A](../ARID1A)|1 |
39 39
|[BCL7A](../BCL7A)|1 |
40 40
|[BTK](../BTK)|1 |
41
-|[CXCR4](../CXCR4)|2 |
42
-|[EGR1](../EGR1)|2 |
43 41
|[HIST1H1B](../HIST1H1B)|1 |
44 42
|[HIST1H1D](../HIST1H1D)|1 |
45 43
|[HIST1H1E](../HIST1H1E)|1 |
... ...
@@ -49,14 +47,21 @@ All other FL studies, FL Tier 2, 45
49 47
|[HIST1H2BC](../HIST1H2BC)|1 |
50 48
|[HIST1H2BD](../HIST1H2BD)|1 |
51 49
|[HIST1H2BG](../HIST1H2BG)|1 |
52
-|[HIST1H2BM](../HIST1H2BM)|2 |
53 50
|[HIST1H3G](../HIST1H3G)|1 |
54
-|[HIST1H3I](../HIST1H3I)|2 |
55 51
|[HVCN1](../HVCN1)|1 |
56 52
|[POU2AF1](../POU2AF1)|1 |
57 53
|[POU2F2](../POU2F2)|1 |
58 54
|[SMARCA4](../SMARCA4)|1 |
55
+
56
+### Tier 2
57
+|New gene|FL tier|
58
+|:-|:-:|
59
+|[CXCR4](../CXCR4)|2 |
60
+|[EGR1](../EGR1)|2 |
61
+|[HIST1H2BM](../HIST1H2BM)|2 |
62
+|[HIST1H3I](../HIST1H3I)|2 |
59 63
|[ZNF608](../ZNF608)|2 |
60 64
65
+
61 66
# Details
62 67
papers/kwanhianMicroRNA142Mutated202012b.md
... ...
@@ -30,12 +30,11 @@ All other DLBCL studies, DLBCL Tier 1, 128
30 30
All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|DLBCL tier|
37 35
|:-|:-:|
38 36
|[MIR142](../MIR142)|2 |
39 37
38
+
40 39
# Details
41 40
papers/lakeMutationsNFKBIAEncoding2009.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[NFKBIA](../NFKBIA)|1 |
39 39
40
+
40 41
# Details
41 42
papers/lenzOncogenicCARD11Mutations2008.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[CARD11](../CARD11)|1 |
39 39
40
+
40 41
# Details
41 42
papers/lohrDiscoveryPrioritizationSomatic2012a.md
... ...
@@ -30,15 +30,20 @@ All other DLBCL studies, DLBCL Tier 1, 125
30 30
All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[ACTB](../ACTB)|1 |
39 39
|[KRAS](../KRAS)|1 |
40 40
|[P2RY8](../P2RY8)|1 |
41
+
42
+### Tier 2
43
+|New gene|DLBCL tier|
44
+|:-|:-:|
41 45
|[PCLO](../PCLO)|2 |
42 46
47
+
43 48
# Details
44 49
papers/louissaintPediatrictypeNodalFollicular2016a.md
... ...
@@ -30,12 +30,13 @@ All other FL studies, FL Tier 1, 65
30 30
All other FL studies, FL Tier 2, 50
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38 38
|[MAP2K1](../MAP2K1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/loveGeneticLandscapeMutations2012.md
... ...
@@ -30,14 +30,20 @@ All other BL studies, BL Tier 1, 26
30 30
All other BL studies, BL Tier 2, 101
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|BL tier|
37
+|:-|:-:|
38
+|[ARID1A](../ARID1A)|1 |
39
+|[GNA13](../GNA13)|1 |
40
+|[PTEN](../PTEN)|1 |
41
+
42
+### Tier 2
36 43
|New gene|BL tier|
37 44
|:-|:-:|
38 45
|[ACAD9](../ACAD9)|2 |
39 46
|[ACE](../ACE)|2 |
40
-|[ARID1A](../ARID1A)|1 |
41 47
|[ATP2C2](../ATP2C2)|2 |
42 48
|[BCL6](../BCL6)|2 |
43 49
|[BRAF](../BRAF)|2 |
... ...
@@ -63,7 +69,6 @@ All other BL studies, BL Tier 2, 101
63 69
|[FGFR3](../FGFR3)|2 |
64 70
|[FTCD](../FTCD)|2 |
65 71
|[GGTLA4](../GGTLA4)|2 |
66
-|[GNA13](../GNA13)|1 |
67 72
|[GRIK5](../GRIK5)|2 |
68 73
|[ICK](../ICK)|2 |
69 74
|[ITPR3](../ITPR3)|2 |
... ...
@@ -78,7 +83,6 @@ All other BL studies, BL Tier 2, 101
78 83
|[POLRMT](../POLRMT)|2 |
79 84
|[POR](../POR)|2 |
80 85
|[PRSS22](../PRSS22)|2 |
81
-|[PTEN](../PTEN)|1 |
82 86
|[PTPRN](../PTPRN)|2 |
83 87
|[RANBP6](../RANBP6)|2 |
84 88
|[RBP3](../RBP3)|2 |
... ...
@@ -95,5 +99,6 @@ All other BL studies, BL Tier 2, 101
95 99
|[TPST2](../TPST2)|2 |
96 100
|[ZNF229](../ZNF229)|2 |
97 101
102
+
98 103
# Details
99 104
papers/mansouriFrequentNFKBIEDeletions2016.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[NFKBIE](../NFKBIE)|1 |
39 39
40
+
40 41
# Details
41 42
papers/mareschalWholeExomeSequencing2016.md
... ...
@@ -30,13 +30,14 @@ All other DLBCL studies, DLBCL Tier 1, 126
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[TBL1XR1](../TBL1XR1)|1 |
39 39
|[XPO1](../XPO1)|1 |
40 40
41
+
41 42
# Details
42 43
papers/morinFrequentMutationHistonemodifying2011.md
... ...
@@ -31,9 +31,9 @@ All other DLBCL studies, DLBCL Tier 1, 101
31 31
All other DLBCL studies, DLBCL Tier 2, 197
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39 39
|[B2M](../B2M)|1 |1 |
... ...
@@ -44,7 +44,6 @@ All other DLBCL studies, DLBCL Tier 2, 197
44 44
|[BTG2](../BTG2)|1 |1 |
45 45
|[CARD11](../CARD11)|1 |1 |
46 46
|[CCND3](../CCND3)|1 |1 |
47
-|[CD274](../CD274)|2 | |
48 47
|[CD58](../CD58)|1 | |
49 48
|[CD70](../CD70)|1 |2 |
50 49
|[CD79B](../CD79B)|1 |2 |
... ...
@@ -65,5 +64,11 @@ All other DLBCL studies, DLBCL Tier 2, 197
65 64
|[TP53](../TP53)|1 |1 |
66 65
|[ZFP36L1](../ZFP36L1)|1 | |
67 66
67
+### Tier 2
68
+|New gene|DLBCL tier|FL tier|
69
+|:-|:-:|:-:|
70
+|[CD274](../CD274)|2 | |
71
+
72
+
68 73
# Details
69 74
papers/morinGeneticLandscapesRelapsed2016.md
... ...
@@ -30,13 +30,14 @@ All other DLBCL studies, DLBCL Tier 1, 126
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[NFKBIE](../NFKBIE)|1 |
39 39
|[NFKBIZ](../NFKBIZ)|1 |
40 40
41
+
41 42
# Details
42 43
papers/morinMutationalStructuralAnalysis2013.md
... ...
@@ -30,34 +30,40 @@ All other DLBCL studies, DLBCL Tier 1, 117
30 30
All other DLBCL studies, DLBCL Tier 2, 169
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[ABI3BP](../ABI3BP)|2 |
39 38
|[CD83](../CD83)|1 |
40
-|[CDH9](../CDH9)|2 |
41 39
|[CDKN2A](../CDKN2A)|1 |
40
+|[DUSP2](../DUSP2)|1 |
41
+|[GNAI2](../GNAI2)|1 |
42
+|[HIST1H1D](../HIST1H1D)|1 |
43
+|[HIST1H1E](../HIST1H1E)|1 |
44
+|[HIST1H2AC](../HIST1H2AC)|1 |
45
+|[IKZF3](../IKZF3)|1 |
46
+|[MPEG1](../MPEG1)|1 |
47
+|[RB1](../RB1)|1 |
48
+|[TAF1](../TAF1)|1 |
49
+
50
+### Tier 2
51
+|New gene|DLBCL tier|
52
+|:-|:-:|
53
+|[ABI3BP](../ABI3BP)|2 |
54
+|[CDH9](../CDH9)|2 |
42 55
|[CNTNAP5](../CNTNAP5)|2 |
43 56
|[DNAH5](../DNAH5)|2 |
44 57
|[DSG4](../DSG4)|2 |
45
-|[DUSP2](../DUSP2)|1 |
46 58
|[FAM38B](../FAM38B)|2 |
47 59
|[FAT4](../FAT4)|2 |
48 60
|[FNDC1](../FNDC1)|2 |
49
-|[GNAI2](../GNAI2)|1 |
50 61
|[HDAC7](../HDAC7)|2 |
51
-|[HIST1H1D](../HIST1H1D)|1 |
52
-|[HIST1H1E](../HIST1H1E)|1 |
53
-|[HIST1H2AC](../HIST1H2AC)|1 |
54 62
|[HIST1H2AG](../HIST1H2AG)|2 |
55 63
|[IER2](../IER2)|2 |
56 64
|[IFNGR1](../IFNGR1)|2 |
57
-|[IKZF3](../IKZF3)|1 |
58 65
|[LRRN3](../LRRN3)|2 |
59 66
|[MPDZ](../MPDZ)|2 |
60
-|[MPEG1](../MPEG1)|1 |
61 67
|[NLRP5](../NLRP5)|2 |
62 68
|[ODZ3](../ODZ3)|2 |
63 69
|[P2RX5](../P2RX5)|2 |
... ...
@@ -68,13 +74,12 @@ All other DLBCL studies, DLBCL Tier 2, 169
68 74
|[POGZ](../POGZ)|2 |
69 75
|[PRKCB](../PRKCB)|2 |
70 76
|[PTPN23](../PTPN23)|2 |
71
-|[RB1](../RB1)|1 |
72 77
|[SAMD9L](../SAMD9L)|2 |
73 78
|[SARM1](../SARM1)|2 |
74 79
|[SRRM2](../SRRM2)|2 |
75 80
|[SYPL1](../SYPL1)|2 |
76
-|[TAF1](../TAF1)|1 |
77 81
|[WDFY3](../WDFY3)|2 |
78 82
83
+
79 84
# Details
80 85
papers/morinSomaticMutationsAltering2010a.md
... ...
@@ -24,19 +24,20 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, DLBCL Tier 1, 1
27
+New Tier 1, FL Tier 1, 1
28 28
This study, New Tier 2, 0
29
-New Tier 2, DLBCL Tier 2, 0
30
-All other DLBCL studies, DLBCL Tier 1, 127
31
-All other DLBCL studies, DLBCL Tier 2, 198
29
+New Tier 2, FL Tier 2, 0
30
+All other FL studies, FL Tier 1, 65
31
+All other FL studies, FL Tier 2, 50
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39 39
|[EZH2](../EZH2)|1 |1 |
40 40
41
+
41 42
# Details
42 43
papers/mottokGenomicAlterationsCIITA2015b.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[CIITA](../CIITA)|1 |
39 39
40
+
40 41
# Details
41 42
papers/mottokIntegrativeGenomicAnalysis2019b.md
... ...
@@ -30,16 +30,23 @@ All other PMBL studies, PMBL Tier 1, 70
30 30
All other PMBL studies, PMBL Tier 2, 67
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[CISH](../CISH)|1 |
39
-|[CXCR5](../CXCR5)|2 |
40 39
|[DDX3X](../DDX3X)|1 |
41
-|[EPHA7](../EPHA7)|2 |
42 40
|[EZH2](../EZH2)|1 |
41
+|[IRF8](../IRF8)|1 |
42
+|[JAK1](../JAK1)|1 |
43
+|[MS4A1](../MS4A1)|1 |
44
+
45
+### Tier 2
46
+|New gene|PMBL tier|
47
+|:-|:-:|
48
+|[CXCR5](../CXCR5)|2 |
49
+|[EPHA7](../EPHA7)|2 |
43 50
|[GCSAM](../GCSAM)|2 |
44 51
|[HIST1H2BC](../HIST1H2BC)|2 |
45 52
|[HIST1H4E](../HIST1H4E)|2 |
... ...
@@ -48,14 +55,12 @@ All other PMBL studies, PMBL Tier 2, 67
48 55
|[IL1RAPL2](../IL1RAPL2)|2 |
49 56
|[IRF2BP2](../IRF2BP2)|2 |
50 57
|[IRF4](../IRF4)|2 |
51
-|[IRF8](../IRF8)|1 |
52
-|[JAK1](../JAK1)|1 |
53 58
|[JUNB](../JUNB)|2 |
54 59
|[MAGEC2](../MAGEC2)|2 |
55
-|[MS4A1](../MS4A1)|1 |
56 60
|[NFKB2](../NFKB2)|2 |
57 61
|[RGS1](../RGS1)|2 |
58 62
|[VMP1](../VMP1)|2 |
59 63
64
+
60 65
# Details
61 66
papers/muppidiLossSignalingGa132014b.md
... ...
@@ -30,14 +30,19 @@ All other BL studies, BL Tier 1, 28
30 30
All other BL studies, BL Tier 2, 155
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ARHGEF1](../ARHGEF1)|2 |
39 38
|[P2RY8](../P2RY8)|1 |
39
+
40
+### Tier 2
41
+|New gene|BL tier|
42
+|:-|:-:|
43
+|[ARHGEF1](../ARHGEF1)|2 |
40 44
|[S1PR2](../S1PR2)|2 |
41 45
46
+
42 47
# Details
43 48
papers/nadeuGenomicEpigenomicInsights2020b.md
... ...
@@ -30,16 +30,21 @@ All other MCL studies, MCL Tier 1, 20
30 30
All other MCL studies, MCL Tier 2, 44
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38
-|[BCOR](../BCOR)|2 |
39 38
|[SMARCA4](../SMARCA4)|1 |
40
-|[SMARCB1](../SMARCB1)|2 |
41 39
|[SYNE1](../SYNE1)|1 |
42 40
|[TERT](../TERT)|1 |
43 41
42
+### Tier 2
43
+|New gene|MCL tier|
44
+|:-|:-:|
45
+|[BCOR](../BCOR)|2 |
46
+|[SMARCB1](../SMARCB1)|2 |
47
+
48
+
44 49
# Details
45 50
papers/ngoOncogenicallyActiveMYD882011a.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[MYD88](../MYD88)|1 |
39 39
40
+
40 41
# Details
41 42
papers/ohgamiSTAT3MutationsAre2014.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[STAT3](../STAT3)|1 |
39 39
40
+
40 41
# Details
41 42
papers/okosunRecurrentMTORC1activatingRRAGC2016a.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|FL|3|0|
12 11
|DLBCL|1|0|
12
+|FL|3|0|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -31,14 +31,15 @@ All other FL studies, FL Tier 1, 63
31 31
All other FL studies, FL Tier 2, 50
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
37
-|New gene|FL tier|DLBCL tier|
36
+### Tier 1
37
+|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[ATP6AP1](../ATP6AP1)|1 | |
40
-|[ATP6V1B2](../ATP6V1B2)|1 | |
39
+|[ATP6AP1](../ATP6AP1)| |1 |
40
+|[ATP6V1B2](../ATP6V1B2)| |1 |
41 41
|[RRAGC](../RRAGC)|1 |1 |
42 42
43
+
43 44
# Details
44 45
papers/oricchioGeneticEpigeneticInactivation2017b.md
... ...
@@ -30,12 +30,11 @@ All other FL studies, FL Tier 1, 66
30 30
All other FL studies, FL Tier 2, 49
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|FL tier|
37 35
|:-|:-:|
38 36
|[SESN1](../SESN1)|2 |
39 37
38
+
40 39
# Details
41 40
papers/ottoGeneticLesionsTRAF32012a.md
... ...
@@ -30,13 +30,14 @@ All other PMBL studies, PMBL Tier 1, 74
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[MAP3K14](../MAP3K14)|1 |
39 39
|[TRAF3](../TRAF3)|1 |
40 40
41
+
41 42
# Details
42 43
papers/paneaWholeGenomeLandscape2019.md
... ...
@@ -30,13 +30,20 @@ All other BL studies, BL Tier 1, 25
30 30
All other BL studies, BL Tier 2, 111
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ALPK2](../ALPK2)|2 |
39 38
|[BMP7](../BMP7)|1 |
39
+|[EIF4A1](../EIF4A1)|1 |
40
+|[EPPK1](../EPPK1)|1 |
41
+|[HNRNPU](../HNRNPU)|1 |
42
+
43
+### Tier 2
44
+|New gene|BL tier|
45
+|:-|:-:|
46
+|[ALPK2](../ALPK2)|2 |
40 47
|[CARD11](../CARD11)|2 |
41 48
|[CD79B](../CD79B)|2 |
42 49
|[CD83](../CD83)|2 |
... ...
@@ -44,9 +51,7 @@ All other BL studies, BL Tier 2, 111
44 51
|[CXCR4](../CXCR4)|2 |
45 52
|[DNMT1](../DNMT1)|2 |
46 53
|[DTX1](../DTX1)|2 |
47
-|[EIF4A1](../EIF4A1)|1 |
48 54
|[EP300](../EP300)|2 |
49
-|[EPPK1](../EPPK1)|1 |
50 55
|[ETS1](../ETS1)|2 |
51 56
|[FZD3](../FZD3)|2 |
52 57
|[GRB2](../GRB2)|2 |
... ...
@@ -59,7 +64,6 @@ All other BL studies, BL Tier 2, 111
59 64
|[HIST1H3I](../HIST1H3I)|2 |
60 65
|[HIST1H3J](../HIST1H3J)|2 |
61 66
|[HIST1H4J](../HIST1H4J)|2 |
62
-|[HNRNPU](../HNRNPU)|1 |
63 67
|[IGLL5](../IGLL5)|2 |
64 68
|[IKZF3](../IKZF3)|2 |
65 69
|[IRF8](../IRF8)|2 |
... ...
@@ -86,5 +90,6 @@ All other BL studies, BL Tier 2, 111
86 90
|[WNK2](../WNK2)|2 |
87 91
|[ZFP36L1](../ZFP36L1)|2 |
88 92
93
+
89 94
# Details
90 95
papers/pararajalingamCodingNoncodingDrivers2020.md
... ...
@@ -31,9 +31,9 @@ All other MCL studies, MCL Tier 1, 17
31 31
All other MCL studies, MCL Tier 2, 45
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|MCL tier|
38 38
|:-|:-:|:-:|
39 39
|[B2M](../B2M)|1 |2 |
... ...
@@ -44,5 +44,6 @@ All other MCL studies, MCL Tier 2, 45
44 44
|[S1PR1](../S1PR1)| |1 |
45 45
|[UBR5](../UBR5)|2 |1 |
46 46
47
+
47 48
# Details
48 49
papers/parryWholeExomeSequencing2013.md
... ...
@@ -31,19 +31,24 @@ All other MZL studies, MZL Tier 1, 42
31 31
All other MZL studies, MZL Tier 2, 66
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37
+|New gene|MZL tier|DLBCL tier|
38
+|:-|:-:|:-:|
39
+|[CREBBP](../CREBBP)|2 |1 |
40
+|[FBXO11](../FBXO11)|2 |1 |
41
+|[TRRAP](../TRRAP)|2 |1 |
42
+
43
+### Tier 2
37 44
|New gene|MZL tier|DLBCL tier|
38 45
|:-|:-:|:-:|
39 46
|[AMOTL1](../AMOTL1)|2 | |
40 47
|[CBFA2T3](../CBFA2T3)|2 | |
41
-|[CREBBP](../CREBBP)|2 |1 |
42 48
|[FAT4](../FAT4)|2 |2 |
43
-|[FBXO11](../FBXO11)|2 |1 |
44 49
|[PLA2G4D](../PLA2G4D)|2 | |
45
-|[TRRAP](../TRRAP)|2 |1 |
46 50
|[USH2A](../USH2A)|2 | |
47 51
52
+
48 53
# Details
49 54
papers/pasqualucciAnalysisCodingGenome2011.md
... ...
@@ -30,18 +30,23 @@ All other DLBCL studies, DLBCL Tier 1, 125
30 30
All other DLBCL studies, DLBCL Tier 2, 194
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CD36](../CD36)|2 |
39 38
|[GRB2](../GRB2)|1 |
40
-|[HNF1B](../HNF1B)|2 |
41 39
|[KLF2](../KLF2)|1 |
42
-|[MYOM2](../MYOM2)|2 |
43 40
|[NOTCH1](../NOTCH1)|1 |
41
+
42
+### Tier 2
43
+|New gene|DLBCL tier|
44
+|:-|:-:|
45
+|[CD36](../CD36)|2 |
46
+|[HNF1B](../HNF1B)|2 |
47
+|[MYOM2](../MYOM2)|2 |
44 48
|[TRAF3](../TRAF3)|2 |
45 49
50
+
46 51
# Details
47 52
papers/pasqualucciHypermutationMultipleProtooncogenes2001a.md
... ...
@@ -30,15 +30,20 @@ All other DLBCL studies, DLBCL Tier 1, 126
30 30
All other DLBCL studies, DLBCL Tier 2, 196
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[MYC](../MYC)|1 |
39
-|[PAX5](../PAX5)|2 |
40 39
|[PIM1](../PIM1)|1 |
40
+
41
+### Tier 2
42
+|New gene|DLBCL tier|
43
+|:-|:-:|
44
+|[PAX5](../PAX5)|2 |
41 45
|[RHOH](../RHOH)|2 |
42 46
47
+
43 48
# Details
44 49
papers/pasqualucciInactivatingMutationsAcetyltransferase2011a.md
... ...
@@ -31,13 +31,14 @@ All other FL studies, FL Tier 1, 64
31 31
All other FL studies, FL Tier 2, 50
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39 39
|[CREBBP](../CREBBP)|1 |1 |
40 40
|[EP300](../EP300)|1 |1 |
41 41
42
+
42 43
# Details
43 44
papers/pasqualucciInactivationPRDM1BLIMP12006a.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[PRDM1](../PRDM1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/reddyGeneticFunctionalDrivers2017.md
... ...
@@ -30,17 +30,26 @@ All other DLBCL studies, DLBCL Tier 1, 121
30 30
All other DLBCL studies, DLBCL Tier 2, 145
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|DLBCL tier|
37
+|:-|:-:|
38
+|[ATM](../ATM)|1 |
39
+|[BIRC6](../BIRC6)|1 |
40
+|[HIST1H2BC](../HIST1H2BC)|1 |
41
+|[HNRNPU](../HNRNPU)|1 |
42
+|[SETD1B](../SETD1B)|1 |
43
+|[TOX](../TOX)|1 |
44
+|[UBE2A](../UBE2A)|1 |
45
+
46
+### Tier 2
36 47
|New gene|DLBCL tier|
37 48
|:-|:-:|
38 49
|[ANKRD17](../ANKRD17)|2 |
39 50
|[ARID1B](../ARID1B)|2 |
40 51
|[ARID5B](../ARID5B)|2 |
41
-|[ATM](../ATM)|1 |
42 52
|[ATR](../ATR)|2 |
43
-|[BIRC6](../BIRC6)|1 |
44 53
|[BRINP3](../BRINP3)|2 |
45 54
|[BTBD3](../BTBD3)|2 |
46 55
|[CASP8](../CASP8)|2 |
... ...
@@ -58,8 +67,6 @@ All other DLBCL studies, DLBCL Tier 2, 145
58 67
|[FUBP1](../FUBP1)|2 |
59 68
|[GNAS](../GNAS)|2 |
60 69
|[GOLGA5](../GOLGA5)|2 |
61
-|[HIST1H2BC](../HIST1H2BC)|1 |
62
-|[HNRNPU](../HNRNPU)|1 |
63 70
|[HRAS](../HRAS)|2 |
64 71
|[IKBKB](../IKBKB)|2 |
65 72
|[JUNB](../JUNB)|2 |
... ...
@@ -83,18 +90,16 @@ All other DLBCL studies, DLBCL Tier 2, 145
83 90
|[PTPRK](../PTPRK)|2 |
84 91
|[RARA](../RARA)|2 |
85 92
|[RUNX1](../RUNX1)|2 |
86
-|[SETD1B](../SETD1B)|1 |
87 93
|[SETD5](../SETD5)|2 |
88 94
|[SYK](../SYK)|2 |
89 95
|[TGFBR2](../TGFBR2)|2 |
90 96
|[TIPARP](../TIPARP)|2 |
91
-|[TOX](../TOX)|1 |
92
-|[UBE2A](../UBE2A)|1 |
93 97
|[WAC](../WAC)|2 |
94 98
|[YY1](../YY1)|2 |
95 99
|[ZBTB7A](../ZBTB7A)|2 |
96 100
|[ZFAT](../ZFAT)|2 |
97 101
|[ZFX](../ZFX)|2 |
98 102
103
+
99 104
# Details
100 105
papers/reichelFlowSortingExome2015a.md
... ...
@@ -30,29 +30,36 @@ All other PMBL studies, PMBL Tier 1, 65
30 30
All other PMBL studies, PMBL Tier 2, 64
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ARIH2](../ARIH2)|2 |
39 38
|[B2M](../B2M)|1 |
40
-|[BCL7A](../BCL7A)|2 |
41 39
|[CSF2RB](../CSF2RB)|1 |
42
-|[DMD](../DMD)|2 |
43 40
|[EBF1](../EBF1)|1 |
44 41
|[EEF1A1](../EEF1A1)|1 |
45
-|[EGR1](../EGR1)|2 |
46 42
|[GNA13](../GNA13)|1 |
43
+|[HIST1H1E](../HIST1H1E)|1 |
44
+|[ITPKB](../ITPKB)|1 |
45
+|[PIM2](../PIM2)|1 |
46
+|[UBE2A](../UBE2A)|1 |
47
+|[WEE1](../WEE1)|1 |
48
+|[ZFP36L1](../ZFP36L1)|1 |
49
+
50
+### Tier 2
51
+|New gene|PMBL tier|
52
+|:-|:-:|
53
+|[ARIH2](../ARIH2)|2 |
54
+|[BCL7A](../BCL7A)|2 |
55
+|[DMD](../DMD)|2 |
56
+|[EGR1](../EGR1)|2 |
47 57
|[HECW2](../HECW2)|2 |
48 58
|[HELLS](../HELLS)|2 |
49
-|[HIST1H1E](../HIST1H1E)|1 |
50 59
|[HIST1H3B](../HIST1H3B)|2 |
51 60
|[HIST1H4C](../HIST1H4C)|2 |
52
-|[ITPKB](../ITPKB)|1 |
53 61
|[MPDZ](../MPDZ)|2 |
54 62
|[NEK1](../NEK1)|2 |
55
-|[PIM2](../PIM2)|1 |
56 63
|[RANBP2](../RANBP2)|2 |
57 64
|[SENP7](../SENP7)|2 |
58 65
|[SETDB1](../SETDB1)|2 |
... ...
@@ -60,10 +67,8 @@ All other PMBL studies, PMBL Tier 2, 64
60 67
|[TBC1D15](../TBC1D15)|2 |
61 68
|[TICRR](../TICRR)|2 |
62 69
|[TRIP11](../TRIP11)|2 |
63
-|[UBE2A](../UBE2A)|1 |
64
-|[WEE1](../WEE1)|1 |
65
-|[ZFP36L1](../ZFP36L1)|1 |
66 70
|[ZNF217](../ZNF217)|2 |
67 71
72
+
68 73
# Details
69 74
papers/richterRecurrentMutationID32012a.md
... ...
@@ -30,9 +30,9 @@ All other BL studies, BL Tier 1, 24
30 30
All other BL studies, BL Tier 2, 157
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38 38
|[CCND3](../CCND3)|1 |
... ...
@@ -41,5 +41,6 @@ All other BL studies, BL Tier 2, 157
41 41
|[RHOA](../RHOA)|1 |
42 42
|[SMARCA4](../SMARCA4)|1 |
43 43
44
+
44 45
# Details
45 46
papers/ritzRecurrentMutationsSTAT62009a.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[STAT6](../STAT6)|1 |
39 39
40
+
40 41
# Details
41 42
papers/rossiAlterationBIRC3Multiple2011a.md
... ...
@@ -30,16 +30,21 @@ All other MZL studies, MZL Tier 1, 38
30 30
All other MZL studies, MZL Tier 2, 73
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38 38
|[BIRC3](../BIRC3)|1 |
39
-|[IKBKB](../IKBKB)|2 |
40 39
|[MAP3K14](../MAP3K14)|1 |
41 40
|[TNFAIP3](../TNFAIP3)|1 |
42 41
|[TRAF3](../TRAF3)|1 |
43 42
43
+### Tier 2
44
+|New gene|MZL tier|
45
+|:-|:-:|
46
+|[IKBKB](../IKBKB)|2 |
47
+
48
+
44 49
# Details
45 50
papers/rossiCodingGenomeSplenic2012c.md
... ...
@@ -31,32 +31,37 @@ All other MZL studies, MZL Tier 1, 32
31 31
All other MZL studies, MZL Tier 2, 63
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|MZL tier|
38 38
|:-|:-:|:-:|
39 39
|[ARID1A](../ARID1A)|1 |1 |
40
-|[CD79A](../CD79A)| |2 |
41 40
|[DTX1](../DTX1)|1 |1 |
42
-|[EGR1](../EGR1)| |2 |
43
-|[EGR2](../EGR2)| |2 |
44 41
|[EP300](../EP300)|1 |1 |
45
-|[GPS2](../GPS2)| |2 |
46
-|[HIST1H2AG](../HIST1H2AG)|2 |2 |
47 42
|[HIST1H2BK](../HIST1H2BK)|1 |2 |
48 43
|[KMT2D](../KMT2D)|1 |1 |
49
-|[MCRS1](../MCRS1)| |2 |
50
-|[MSL2](../MSL2)| |2 |
51 44
|[NOTCH1](../NOTCH1)|1 |1 |
52 45
|[NOTCH2](../NOTCH2)|1 |1 |
53 46
|[SIN3A](../SIN3A)|1 |1 |
54 47
|[SPEN](../SPEN)|1 |1 |
55
-|[SWAP70](../SWAP70)| |2 |
56 48
|[TBL1XR1](../TBL1XR1)|1 |1 |
57 49
|[TP53](../TP53)|1 |1 |
58 50
|[TRRAP](../TRRAP)|1 |2 |
51
+
52
+### Tier 2
53
+|New gene|DLBCL tier|MZL tier|
54
+|:-|:-:|:-:|
55
+|[CD79A](../CD79A)| |2 |
56
+|[EGR1](../EGR1)| |2 |
57
+|[EGR2](../EGR2)| |2 |
58
+|[GPS2](../GPS2)| |2 |
59
+|[HIST1H2AG](../HIST1H2AG)|2 |2 |
60
+|[MCRS1](../MCRS1)| |2 |
61
+|[MSL2](../MSL2)| |2 |
62
+|[SWAP70](../SWAP70)| |2 |
59 63
|[WAC](../WAC)|2 |2 |
60 64
65
+
61 66
# Details
62 67
papers/rushtonGeneticEvolutionaryPatterns2020.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[MS4A1](../MS4A1)|1 |
39 39
40
+
40 41
# Details
41 42
papers/russler-germainMutationsAssociatedProgression2023b.md
... ...
@@ -30,15 +30,19 @@ All other FL studies, FL Tier 1, 65
30 30
All other FL studies, FL Tier 2, 31
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|FL tier|
37
+|:-|:-:|
38
+|[CD83](../CD83)|1 |
39
+
40
+### Tier 2
36 41
|New gene|FL tier|
37 42
|:-|:-:|
38 43
|[ABL2](../ABL2)|2 |
39 44
|[BCL10](../BCL10)|2 |
40 45
|[CD70](../CD70)|2 |
41
-|[CD83](../CD83)|1 |
42 46
|[CILP](../CILP)|2 |
43 47
|[CYP2A6](../CYP2A6)|2 |
44 48
|[GBP7](../GBP7)|2 |
... ...
@@ -56,5 +60,6 @@ All other FL studies, FL Tier 2, 31
56 60
|[STAB2](../STAB2)|2 |
57 61
|[XIRP2](../XIRP2)|2 |
58 62
63
+
59 64
# Details
60 65
papers/sarkozyMutationalLandscapeGray2021a.md
... ...
@@ -30,22 +30,27 @@ All other PMBL studies, PMBL Tier 1, 71
30 30
All other PMBL studies, PMBL Tier 2, 76
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ABCA13](../ABCA13)|2 |
39
-|[BCL2](../BCL2)|2 |
40 38
|[BIRC6](../BIRC6)|1 |
41 39
|[BTG1](../BTG1)|1 |
42 40
|[HIST1H1B](../HIST1H1B)|1 |
43 41
|[KMT2C](../KMT2C)|1 |
42
+|[SPEN](../SPEN)|1 |
43
+
44
+### Tier 2
45
+|New gene|PMBL tier|
46
+|:-|:-:|
47
+|[ABCA13](../ABCA13)|2 |
48
+|[BCL2](../BCL2)|2 |
44 49
|[LRRN3](../LRRN3)|2 |
45 50
|[MFHAS1](../MFHAS1)|2 |
46 51
|[NCOR2](../NCOR2)|2 |
47 52
|[RELN](../RELN)|2 |
48
-|[SPEN](../SPEN)|1 |
53
+
49 54
50 55
# Details
51 56
papers/schmitzBurkittLymphomaPathogenesis2012.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|BL|4|16|
12 11
|DLBCL|2|3|
12
+|BL|4|16|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -31,31 +31,36 @@ All other BL studies, BL Tier 1, 25
31 31
All other BL studies, BL Tier 2, 141
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
37
-|New gene|BL tier|DLBCL tier|
36
+### Tier 1
37
+|New gene|DLBCL tier|BL tier|
38 38
|:-|:-:|:-:|
39
-|[C16orf48](../C16orf48)|2 | |
40 39
|[DDX3X](../DDX3X)|1 |1 |
41
-|[DHCR7](../DHCR7)|2 | |
42
-|[ELP2](../ELP2)|2 | |
43
-|[EXOSC6](../EXOSC6)|2 | |
44
-|[FLYWCH1](../FLYWCH1)|2 | |
45 40
|[FOXO1](../FOXO1)|1 |1 |
46
-|[GTSE1](../GTSE1)|2 | |
47
-|[ID3](../ID3)|1 |2 |
48
-|[KANK2](../KANK2)|2 | |
49
-|[MKI67](../MKI67)|2 | |
50
-|[MYO18A](../MYO18A)|2 | |
41
+|[ID3](../ID3)|2 |1 |
42
+|[TCF3](../TCF3)| |1 |
43
+
44
+### Tier 2
45
+|New gene|DLBCL tier|BL tier|
46
+|:-|:-:|:-:|
47
+|[C16orf48](../C16orf48)| |2 |
48
+|[DHCR7](../DHCR7)| |2 |
49
+|[ELP2](../ELP2)| |2 |
50
+|[EXOSC6](../EXOSC6)| |2 |
51
+|[FLYWCH1](../FLYWCH1)| |2 |
52
+|[GTSE1](../GTSE1)| |2 |
53
+|[KANK2](../KANK2)| |2 |
54
+|[MKI67](../MKI67)| |2 |
55
+|[MYO18A](../MYO18A)| |2 |
51 56
|[NCOR2](../NCOR2)|2 |2 |
52 57
|[PCBP1](../PCBP1)|2 |2 |
53
-|[PDCD11](../PDCD11)|2 | |
54
-|[TCF3](../TCF3)|1 | |
55
-|[TOP2A](../TOP2A)|2 | |
56
-|[WDR90](../WDR90)|2 | |
57
-|[WHAMM](../WHAMM)|2 | |
58
-|[YY1AP1](../YY1AP1)|2 | |
58
+|[PDCD11](../PDCD11)| |2 |
59
+|[TOP2A](../TOP2A)| |2 |
60
+|[WDR90](../WDR90)| |2 |
61
+|[WHAMM](../WHAMM)| |2 |
62
+|[YY1AP1](../YY1AP1)| |2 |
63
+
59 64
60 65
# Details
61 66
papers/schmitzGeneticsPathogenesisDiffuse2018a.md
... ...
@@ -30,27 +30,32 @@ All other DLBCL studies, DLBCL Tier 1, 121
30 30
All other DLBCL studies, DLBCL Tier 2, 189
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[CXCR5](../CXCR5)|1 |
39 39
|[DDX3X](../DDX3X)|1 |
40 40
|[DTX1](../DTX1)|1 |
41
+|[HIST2H2BE](../HIST2H2BE)|1 |
42
+|[ITPKB](../ITPKB)|1 |
43
+|[NOL9](../NOL9)|1 |
44
+|[WEE1](../WEE1)|1 |
45
+
46
+### Tier 2
47
+|New gene|DLBCL tier|
48
+|:-|:-:|
41 49
|[FOXC1](../FOXC1)|2 |
42 50
|[GPC5](../GPC5)|2 |
43 51
|[GSG2](../GSG2)|2 |
44
-|[HIST2H2BE](../HIST2H2BE)|1 |
45
-|[ITPKB](../ITPKB)|1 |
46 52
|[KLHL21](../KLHL21)|2 |
47 53
|[LAMA5](../LAMA5)|2 |
48 54
|[MYBPC2](../MYBPC2)|2 |
49
-|[NOL9](../NOL9)|1 |
50 55
|[PAPOLG](../PAPOLG)|2 |
51 56
|[PRKDC](../PRKDC)|2 |
52 57
|[TAP1](../TAP1)|2 |
53
-|[WEE1](../WEE1)|1 |
58
+
54 59
55 60
# Details
56 61
papers/schmitzTNFAIP3A20Tumor2009a.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[TNFAIP3](../TNFAIP3)|1 |
39 39
40
+
40 41
# Details
41 42
papers/schneiderAlterationsCD58Gene2015a.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[CD58](../CD58)|1 |
39 39
40
+
40 41
# Details
41 42
papers/schollMutationsRegionFAS2007.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[FAS](../FAS)|1 |
39 39
40
+
40 41
# Details
41 42
papers/shinBRAFV600EMAP2K12015.md
... ...
@@ -30,12 +30,11 @@ All other DLBCL studies, DLBCL Tier 1, 128
30 30
All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|DLBCL tier|
37 35
|:-|:-:|
38 36
|[MAP2K1](../MAP2K1)|2 |
39 37
38
+
40 39
# Details
41 40
papers/spinaGeneticsNodalMarginal2016b.md
... ...
@@ -30,9 +30,21 @@ All other MZL studies, MZL Tier 1, 34
30 30
All other MZL studies, MZL Tier 2, 51
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|MZL tier|
37
+|:-|:-:|
38
+|[BCL10](../BCL10)|1 |
39
+|[FAS](../FAS)|1 |
40
+|[FAT1](../FAT1)|1 |
41
+|[ID3](../ID3)|1 |
42
+|[NCOR2](../NCOR2)|1 |
43
+|[NOL9](../NOL9)|1 |
44
+|[PTPRD](../PTPRD)|1 |
45
+|[TNFRSF14](../TNFRSF14)|1 |
46
+
47
+### Tier 2
36 48
|New gene|MZL tier|
37 49
|:-|:-:|
38 50
|[ABCA13](../ABCA13)|2 |
... ...
@@ -40,23 +52,16 @@ All other MZL studies, MZL Tier 2, 51
40 52
|[ADD2](../ADD2)|2 |
41 53
|[AMN](../AMN)|2 |
42 54
|[AOC2](../AOC2)|2 |
43
-|[BCL10](../BCL10)|1 |
44 55
|[C6orf103](../C6orf103)|2 |
45 56
|[CDC42BPB](../CDC42BPB)|2 |
46 57
|[CDKN2A](../CDKN2A)|2 |
47 58
|[CLGN](../CLGN)|2 |
48 59
|[CNKSR2](../CNKSR2)|2 |
49
-|[FAS](../FAS)|1 |
50
-|[FAT1](../FAT1)|1 |
51 60
|[GPR98](../GPR98)|2 |
52
-|[ID3](../ID3)|1 |
53 61
|[LRP1B](../LRP1B)|2 |
54
-|[NCOR2](../NCOR2)|1 |
55
-|[NOL9](../NOL9)|1 |
56 62
|[PACRG](../PACRG)|2 |
57 63
|[PARK2](../PARK2)|2 |
58 64
|[PLXNB3](../PLXNB3)|2 |
59
-|[PTPRD](../PTPRD)|1 |
60 65
|[RCOR1](../RCOR1)|2 |
61 66
|[RPL1L](../RPL1L)|2 |
62 67
|[SAMD5](../SAMD5)|2 |
... ...
@@ -64,8 +69,8 @@ All other MZL studies, MZL Tier 2, 51
64 69
|[STXBP5](../STXBP5)|2 |
65 70
|[TAF1](../TAF1)|2 |
66 71
|[TCTN2](../TCTN2)|2 |
67
-|[TNFRSF14](../TNFRSF14)|1 |
68 72
|[ZNF9](../ZNF9)|2 |
69 73
74
+
70 75
# Details
71 76
papers/tanakaFrequentIncidenceSomatic1992.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[BCL2](../BCL2)|1 |
39 39
40
+
40 41
# Details
41 42
papers/thomasGeneticSubgroupsInform2023.md
... ...
@@ -30,16 +30,21 @@ All other BL studies, BL Tier 1, 27
30 30
All other BL studies, BL Tier 2, 154
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|BL tier|
37
+|:-|:-:|
38
+|[PHF6](../PHF6)|1 |
39
+|[WNK1](../WNK1)|1 |
40
+
41
+### Tier 2
36 42
|New gene|BL tier|
37 43
|:-|:-:|
38 44
|[CDKN2C](../CDKN2C)|2 |
39 45
|[EBF1](../EBF1)|2 |
40 46
|[EHD1](../EHD1)|2 |
41
-|[PHF6](../PHF6)|1 |
42
-|[WNK1](../WNK1)|1 |
47
+
43 48
44 49
# Details
45 50
papers/tiacciBRAFMutationsHairycell2011a.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[BRAF](../BRAF)|1 |
39 39
40
+
40 41
# Details
41 42
papers/tiacciPervasiveMutationsJAKSTAT2018b.md
... ...
@@ -30,9 +30,14 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 73
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|PMBL tier|
37
+|:-|:-:|
38
+|[TP53](../TP53)|1 |
39
+
40
+### Tier 2
36 41
|New gene|PMBL tier|
37 42
|:-|:-:|
38 43
|[AKAP6](../AKAP6)|2 |
... ...
@@ -43,8 +48,8 @@ All other PMBL studies, PMBL Tier 2, 73
43 48
|[SETD5](../SETD5)|2 |
44 49
|[STAT5B](../STAT5B)|2 |
45 50
|[TNIP1](../TNIP1)|2 |
46
-|[TP53](../TP53)|1 |
47 51
|[ZCCHC11](../ZCCHC11)|2 |
48 52
53
+
49 54
# Details
50 55
papers/troenNOTCH2MutationsMarginal2008.md
... ...
@@ -30,12 +30,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
30 30
All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[NOTCH2](../NOTCH2)|1 |
39 39
40
+
40 41
# Details
41 42
papers/vandenbrandRecurrentMutationsGenes2017.md
... ...
@@ -30,13 +30,12 @@ All other MZL studies, MZL Tier 1, 42
30 30
All other MZL studies, MZL Tier 2, 72
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|MZL tier|
37 35
|:-|:-:|
38 36
|[CD9B](../CD9B)|2 |
39 37
|[TNIP2](../TNIP2)|2 |
40 38
39
+
41 40
# Details
42 41
papers/viganoSomaticIL4RMutations2018b.md
... ...
@@ -30,12 +30,13 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[IL4R](../IL4R)|1 |
39 39
40
+
40 41
# Details
41 42
papers/wenigerMutationsTumorSuppressor2006a.md
... ...
@@ -30,13 +30,18 @@ All other PMBL studies, PMBL Tier 1, 75
30 30
All other PMBL studies, PMBL Tier 2, 81
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[GPR126](../GPR126)|2 |
39 38
|[SOCS1](../SOCS1)|1 |
40 39
40
+### Tier 2
41
+|New gene|PMBL tier|
42
+|:-|:-:|
43
+|[GPR126](../GPR126)|2 |
44
+
45
+
41 46
# Details
42 47
papers/wienandGenomicAnalysesFlowsorted2019b.md
... ...
@@ -30,18 +30,23 @@ All other PMBL studies, PMBL Tier 1, 72
30 30
All other PMBL studies, PMBL Tier 2, 79
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38 38
|[ACTB](../ACTB)|1 |
39 39
|[ARID1A](../ARID1A)|1 |
40
-|[DNAH12](../DNAH12)|2 |
41 40
|[HLA-B](../HLA-B)|1 |
42
-|[IKBKB](../IKBKB)|2 |
43 41
|[NFKBIA](../NFKBIA)|1 |
42
+
43
+### Tier 2
44
+|New gene|PMBL tier|
45
+|:-|:-:|
46
+|[DNAH12](../DNAH12)|2 |
47
+|[IKBKB](../IKBKB)|2 |
44 48
|[RBM38](../RBM38)|2 |
45 49
50
+
46 51
# Details
47 52
papers/wildaInactivationARFMDM2p53Pathway2004.md
... ...
@@ -30,12 +30,13 @@ All other BL studies, BL Tier 1, 28
30 30
All other BL studies, BL Tier 2, 157
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38 38
|[TP53](../TP53)|1 |
39 39
40
+
40 41
# Details
41 42
papers/wuGeneticHeterogeneityPrimary2016.md
... ...
@@ -30,12 +30,13 @@ All other MCL studies, MCL Tier 1, 22
30 30
All other MCL studies, MCL Tier 2, 46
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38 38
|[CARD11](../CARD11)|1 |
39 39
40
+
40 41
# Details
41 42
papers/yanBCRTLRSignaling2012a.md
... ...
@@ -30,13 +30,14 @@ All other MZL studies, MZL Tier 1, 40
30 30
All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38 38
|[CARD11](../CARD11)|1 |
39 39
|[MYD88](../MYD88)|1 |
40 40
41
+
41 42
# Details
42 43
papers/yildizActivatingSTAT6Mutations2015c.md
... ...
@@ -31,12 +31,13 @@ All other DLBCL studies, DLBCL Tier 1, 127
31 31
All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34
-
35 34
## Novel genes reported in this study
36 35
36
+### Tier 1
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39 39
|[STAT6](../STAT6)|1 |1 |
40 40
41
+
41 42
# Details
42 43
papers/zhangGeneticHeterogeneityDiffuse2013.md
... ...
@@ -30,30 +30,35 @@ All other DLBCL studies, DLBCL Tier 1, 117
30 30
All other DLBCL studies, DLBCL Tier 2, 190
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38 38
|[ARID1A](../ARID1A)|1 |
39 39
|[FBXW7](../FBXW7)|1 |
40 40
|[HIST1H3B](../HIST1H3B)|1 |
41
-|[INO80](../INO80)|2 |
42
-|[JAK1](../JAK1)|2 |
43
-|[JAK3](../JAK3)|2 |
44 41
|[KLHL14](../KLHL14)|1 |
45 42
|[KMT2C](../KMT2C)|1 |
46 43
|[MGA](../MGA)|1 |
47 44
|[MTOR](../MTOR)|1 |
48
-|[PIK3R1](../PIK3R1)|2 |
49 45
|[POU2F2](../POU2F2)|1 |
50
-|[SETD2](../SETD2)|2 |
51 46
|[SMARCA4](../SMARCA4)|1 |
47
+|[ZNF292](../ZNF292)|1 |
48
+|[ZNF608](../ZNF608)|1 |
49
+
50
+### Tier 2
51
+|New gene|DLBCL tier|
52
+|:-|:-:|
53
+|[INO80](../INO80)|2 |
54
+|[JAK1](../JAK1)|2 |
55
+|[JAK3](../JAK3)|2 |
56
+|[PIK3R1](../PIK3R1)|2 |
57
+|[SETD2](../SETD2)|2 |
52 58
|[STAT5B](../STAT5B)|2 |
53 59
|[UBR5](../UBR5)|2 |
54 60
|[ZEB2](../ZEB2)|2 |
55
-|[ZNF292](../ZNF292)|1 |
56
-|[ZNF608](../ZNF608)|1 |
61
+
57 62
58 63
# Details
59 64
papers/zhangGenomicLandscapeMantle2014.md
... ...
@@ -30,9 +30,15 @@ All other MCL studies, MCL Tier 1, 21
30 30
All other MCL studies, MCL Tier 2, 20
31 31
```
32 32
33
-
34 33
## Novel genes reported in this study
35 34
35
+### Tier 1
36
+|New gene|MCL tier|
37
+|:-|:-:|
38
+|[POT1](../POT1)|1 |
39
+|[RB1](../RB1)|1 |
40
+
41
+### Tier 2
36 42
|New gene|MCL tier|
37 43
|:-|:-:|
38 44
|[ANK2](../ANK2)|2 |
... ...
@@ -54,8 +60,6 @@ All other MCL studies, MCL Tier 2, 20
54 60
|[OGDHL](../OGDHL)|2 |
55 61
|[PCDHB2](../PCDHB2)|2 |
56 62
|[PLXNB3](../PLXNB3)|2 |
57
-|[POT1](../POT1)|1 |
58
-|[RB1](../RB1)|1 |
59 63
|[ROBO2](../ROBO2)|2 |
60 64
|[SALL3](../SALL3)|2 |
61 65
|[SI](../SI)|2 |
... ...
@@ -64,5 +68,6 @@ All other MCL studies, MCL Tier 2, 20
64 68
|[ZNF117](../ZNF117)|2 |
65 69
|[ZNF296](../ZNF296)|2 |
66 70
71
+
67 72
# Details
68 73
papers/zhouSporadicEndemicBurkitt2019.md
... ...
@@ -30,12 +30,11 @@ All other BL studies, BL Tier 1, 29
30 30
All other BL studies, BL Tier 2, 156
31 31
```
32 32
33
-
34
-## Novel genes reported in this study
35
-
33
+### Tier 2
36 34
|New gene|BL tier|
37 35
|:-|:-:|
38 36
|[KMT2C](../KMT2C)|2 |
39 37
38
+
40 39
# Details
41 40